Mylan Pharmaceuticals Inc recalls Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside
Recalled May 4, 2022 · FDA recall D-0845-2022 · Mylan Pharmaceuticals
Hazard
Labeling: Missing label on the vial · FDA Class I
Units
89,665 vials
Sold at
USA nationwide.
Description
Labeling: Missing label on the vial
Product
Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80
Manufacturer(s)
Mylan Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →